학술논문

Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks.
Document Type
Article
Source
AIDS & Behavior; Dec2020, Vol. 24 Issue 12, p3533-3544, 12p, 1 Diagram, 1 Chart, 4 Graphs
Subject
HEALTH status indicators
HIV infections
INJECTIONS
ORAL drug administration
HEALTH outcome assessment
PATIENT satisfaction
QUESTIONNAIRES
ANTIRETROVIRAL agents
HUMAN research subjects
HIV integrase inhibitors
NON-nucleoside reverse transcriptase inhibitors
PATIENTS' attitudes
DESCRIPTIVE statistics
Language
ISSN
10907165
Abstract
Copyright of AIDS & Behavior is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)